Group of leading academics say Humira patent thicketing antitrust issues must be looked at again

Group of leading academics say Humira patent thicketing antitrust issues must be looked at again

Professors seek reversal of original district court decision, following the dismissal of a potential landmark dispute over the nature of sham litigation

Unlock unlimited access to all IAM content